UNSPSC 51263124: Indopanolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2JQ3661CAD. European Medicines Agency schedules Indopanolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08181MIG. Indopanolol generally arises in the molecular formula C20H23CLN2O3.

UNSPSC 51263124 Indopanolol is a Commodity code, but the recent state and local procurement activity tagged under it does not match its nominal scope — the sole available opportunity concerns naloxone and drug deactivation systems, not indopanolol (an antihypertensive pharmaceutical). State and local governments appear to use this code inconsistently or inaccurately when procuring opioid-reversal agents and harm-reduction equipment, suggesting either a taxonomy misalignment in the issuing jurisdiction's system or a data-entry error at the point of posting.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries an initial two-year term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and workers' compensation and professional liability insurance. The procurement does not carry explicit set-aside designations. The source does not identify additional recent opportunities under this code, and the naloxone / drug deactivation systems scope suggests that relying on this UNSPSC code for targeting pharmaceutical or medical-device procurement in the state and local market would be unreliable without direct source verification.